메뉴 건너뛰기




Volumn 6, Issue , 2010, Pages

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Novel findings using a simulated adult workplace environment design

Author keywords

[No Author keywords available]

Indexed keywords

LISDEXAMFETAMINE; PLACEBO; DEXAMPHETAMINE; PSYCHOTROPIC AGENT;

EID: 77955140309     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-34     Document Type: Article
Times cited : (125)

References (37)
  • 3
    • 33646812224 scopus 로고    scopus 로고
    • Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community
    • 10.4088/JCP.v67n0403, 16669717
    • Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 2006, 67:524-540. 10.4088/JCP.v67n0403, 16669717.
    • (2006) J Clin Psychiatry , vol.67 , pp. 524-540
    • Biederman, J.1    Faraone, S.V.2    Spencer, T.J.3    Mick, E.4    Monuteaux, M.C.5    Aleardi, M.6
  • 4
    • 29044434211 scopus 로고    scopus 로고
    • A simulated workplace experience for nonmedicated adults with and without ADHD
    • 10.1176/appi.ps.56.12.1617, 16339631
    • Biederman J, Mick E, Fried R, Aleardi M, Potter A, Herzig K. A simulated workplace experience for nonmedicated adults with and without ADHD. Psychiatr Serv 2005, 56:1617-1620. 10.1176/appi.ps.56.12.1617, 16339631.
    • (2005) Psychiatr Serv , vol.56 , pp. 1617-1620
    • Biederman, J.1    Mick, E.2    Fried, R.3    Aleardi, M.4    Potter, A.5    Herzig, K.6
  • 5
    • 0029145666 scopus 로고
    • Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review
    • 10.1097/00004714-199508000-00006, 7593710
    • Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 1995, 15:270-279. 10.1097/00004714-199508000-00006, 7593710.
    • (1995) J Clin Psychopharmacol , vol.15 , pp. 270-279
    • Wilens, T.E.1    Biederman, J.2    Spencer, T.J.3    Prince, J.4
  • 6
    • 3042693000 scopus 로고    scopus 로고
    • Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care
    • 10.1001/archinte.164.11.1221, 15197048
    • Faraone SV, Spencer TJ, Montano CB, Biederman J. Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med 2004, 164:1221-1226. 10.1001/archinte.164.11.1221, 15197048.
    • (2004) Arch Intern Med , vol.164 , pp. 1221-1226
    • Faraone, S.V.1    Spencer, T.J.2    Montano, C.B.3    Biederman, J.4
  • 8
    • 16244362634 scopus 로고    scopus 로고
    • A clinical perspective of attention-deficit/hyperactivity disorder into adulthood
    • 10.4088/JCP.v65n1003, 15491232
    • Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry 2004, 65:1301-1313. 10.4088/JCP.v65n1003, 15491232.
    • (2004) J Clin Psychiatry , vol.65 , pp. 1301-1313
    • Wilens, T.E.1    Dodson, W.2
  • 9
    • 33846006876 scopus 로고    scopus 로고
    • Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder
    • 10.1185/030079906X154132, 17166338
    • Fallu A, Richard C, Prinzo R, Binder C. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Curr Med Res Opin 2006, 22:2557-2566. 10.1185/030079906X154132, 17166338.
    • (2006) Curr Med Res Opin , vol.22 , pp. 2557-2566
    • Fallu, A.1    Richard, C.2    Prinzo, R.3    Binder, C.4
  • 11
    • 0029062077 scopus 로고
    • A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder
    • Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995, 52:434-443.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 434-443
    • Spencer, T.1    Wilens, T.2    Biederman, J.3    Faraone, S.V.4    Ablon, J.S.5    Lapey, K.6
  • 12
    • 33747380598 scopus 로고    scopus 로고
    • Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial
    • SLI381.303 Study Group
    • Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ, . SLI381.303 Study Group Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 2006, 11:625-639. SLI381.303 Study Group.
    • (2006) CNS Spectr , vol.11 , pp. 625-639
    • Weisler, R.H.1    Biederman, J.2    Spencer, T.J.3    Wilens, T.E.4    Faraone, S.V.5    Chrisman, A.K.6    Read, S.C.7    Tulloch, S.J.8
  • 13
    • 77955139288 scopus 로고    scopus 로고
    • Absorption of the prodrug lisdexamfetamine dimesylate and its subsequent enzymatic conversion to the active moiety d-amphetamine
    • Pennick M. Absorption of the prodrug lisdexamfetamine dimesylate and its subsequent enzymatic conversion to the active moiety d-amphetamine. Neuropsych Dis Treat 6:317-327.
    • Neuropsych Dis Treat , vol.6 , pp. 317-327
    • Pennick, M.1
  • 15
    • 34948906993 scopus 로고    scopus 로고
    • Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study
    • 10.1016/j.biopsych.2007.04.015, 17631866
    • Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry 2007, 62:970-976. 10.1016/j.biopsych.2007.04.015, 17631866.
    • (2007) Biol Psychiatry , vol.62 , pp. 970-976
    • Biederman, J.1    Boellner, S.W.2    Childress, A.3    Lopez, F.A.4    Krishnan, S.5    Zhang, Y.6
  • 16
    • 67650225546 scopus 로고    scopus 로고
    • A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
    • 2704174, 19508731, 311 Study Group
    • Wigal SB, Kollins SH, Childress AC, Squires L, . 311 Study Group A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health 2009, 3:17. 2704174, 19508731, 311 Study Group.
    • (2009) Child Adolesc Psychiatry Ment Health , vol.3 , pp. 17
    • Wigal, S.B.1    Kollins, S.H.2    Childress, A.C.3    Squires, L.4
  • 17
    • 34247257281 scopus 로고    scopus 로고
    • Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
    • 10.1016/S0149-2918(07)80083-X, 17577466
    • Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther 2007, 29:450-463. 10.1016/S0149-2918(07)80083-X, 17577466.
    • (2007) Clin Ther , vol.29 , pp. 450-463
    • Biederman, J.1    Krishnan, S.2    Zhang, Y.3    McGough, J.J.4    Findling, R.L.5
  • 18
    • 52649161328 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    • 10.4088/JCP.v69n0903, 19012818, 303 Study Group
    • Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J, . 303 Study Group Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008, 69:1364-1373. 10.4088/JCP.v69n0903, 19012818, 303 Study Group.
    • (2008) J Clin Psychiatry , vol.69 , pp. 1364-1373
    • Adler, L.A.1    Goodman, D.W.2    Kollins, S.H.3    Weisler, R.H.4    Krishnan, S.5    Zhang, Y.6    Biederman, J.7
  • 19
    • 46749142537 scopus 로고    scopus 로고
    • Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder
    • 10.1517/14656566.9.9.1565, 18518785
    • Faraone SV. Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder. Expert Opin Pharmacother 2008, 9:1565-1574. 10.1517/14656566.9.9.1565, 18518785.
    • (2008) Expert Opin Pharmacother , vol.9 , pp. 1565-1574
    • Faraone, S.V.1
  • 20
    • 77954716591 scopus 로고    scopus 로고
    • Advances in the treatment of adult ADHD--landmark findings in nonstimulant therapy
    • Accessed April 13, 2009
    • Weiss M, Bailey R. Advances in the treatment of adult ADHD--landmark findings in nonstimulant therapy. Accessed April 13, 2009., http://www.medscape.com/viewarticle/458059_1
    • Weiss, M.1    Bailey, R.2
  • 21
    • 33745962119 scopus 로고    scopus 로고
    • The laboratory school protocol: its origin, use, and new applications
    • 10.1177/1087054705286049, 16840597
    • Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord 2006, 10:92-111. 10.1177/1087054705286049, 16840597.
    • (2006) J Atten Disord , vol.10 , pp. 92-111
    • Wigal, S.B.1    Wigal, T.L.2
  • 24
    • 46749156887 scopus 로고    scopus 로고
    • A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect
    • 10.2165/00023210-200822080-00006, 18601306
    • Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect. CNS Drugs 2008, 22:693-704. 10.2165/00023210-200822080-00006, 18601306.
    • (2008) CNS Drugs , vol.22 , pp. 693-704
    • Brams, M.1    Muniz, R.2    Childress, A.3    Giblin, J.4    Mao, A.5    Turnbow, J.6    Borrello, M.7    McCague, K.8    Lopez, F.A.9    Silva, R.10
  • 25
    • 1642367699 scopus 로고    scopus 로고
    • A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The Comacs Study)
    • 10.1542/peds.113.3.e206, 14993578, COMACS Study Group
    • Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, . COMACS Study Group A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The Comacs Study). Pediatrics 2004, 113:e206-e216. 10.1542/peds.113.3.e206, 14993578, COMACS Study Group.
    • (2004) Pediatrics , vol.113
    • Swanson, J.M.1    Wigal, S.B.2    Wigal, T.3    Sonuga-Barke, E.4    Greenhill, L.L.5    Biederman, J.6    Kollins, S.7    Nguyen, A.S.8    DeCory, H.H.9    Hirshe Dirksen, S.J.10    Hatch, S.J.11
  • 27
    • 20444385265 scopus 로고    scopus 로고
    • The Adult ADHD Clinical Diagnostic Scale (ACDS) v1.2
    • New York, NY: New York University School of Medicine
    • Adler L, Spencer T. The Adult ADHD Clinical Diagnostic Scale (ACDS) v1.2. 2004, New York, NY: New York University School of Medicine.
    • (2004)
    • Adler, L.1    Spencer, T.2
  • 28
    • 0003895554 scopus 로고    scopus 로고
    • KBIT-2: Kaufman Brief Intelligence Test
    • Upper Saddle River, NJ: Pearson Education, Inc, Second
    • Kaufman AS, Kaufman NL. KBIT-2: Kaufman Brief Intelligence Test. 2004, Upper Saddle River, NJ: Pearson Education, Inc, Second.
    • (2004)
    • Kaufman, A.S.1    Kaufman, N.L.2
  • 29
    • 0003558472 scopus 로고    scopus 로고
    • ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation
    • New York, NY: Guilford Press
    • DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. 1998, New York, NY: Guilford Press.
    • (1998)
    • DuPaul, G.J.1    Power, T.J.2    Anastopoulos, A.D.3    Reid, R.4
  • 30
    • 1842477104 scopus 로고    scopus 로고
    • Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
    • 10.1016/j.psc.2003.12.003, 15063992
    • Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004, 27:187-201. 10.1016/j.psc.2003.12.003, 15063992.
    • (2004) Psychiatr Clin North Am , vol.27 , pp. 187-201
    • Adler, L.1    Cohen, J.2
  • 31
    • 70849132384 scopus 로고    scopus 로고
    • ADHD-RS Initial Evaluation
    • Accessed August 12, 2009
    • ADHD-RS Initial Evaluation. Accessed August 12, 2009., http://www.askdrjones.com/wp-content/uploads/patientforms/ADHD%20Screening-Initial%20Eval.pdf
  • 32
    • 0000238671 scopus 로고
    • Clinical global impressions
    • Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch
    • Guy W. Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology 1976, 218-222. Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch.
    • (1976) ECDEU Assessment Manual for Psychopharmacology , pp. 218-222
    • Guy, W.1
  • 33
    • 33745144300 scopus 로고    scopus 로고
    • Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder
    • 10.1089/cap.2006.16.239, 16768632
    • Silva RR, Muniz R, Pestreich L, Childress A, Brams M, Lopez FA, Wang J. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2006, 16:239-251. 10.1089/cap.2006.16.239, 16768632.
    • (2006) J Child Adolesc Psychopharmacol , vol.16 , pp. 239-251
    • Silva, R.R.1    Muniz, R.2    Pestreich, L.3    Childress, A.4    Brams, M.5    Lopez, F.A.6    Wang, J.7
  • 34
    • 0037317368 scopus 로고    scopus 로고
    • Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies
    • 10.1001/archpsyc.60.2.204, 12578439
    • Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 2003, 60:204-211. 10.1001/archpsyc.60.2.204, 12578439.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 204-211
    • Swanson, J.1    Gupta, S.2    Lam, A.3    Shoulson, I.4    Lerner, M.5    Modi, N.6    Lindemulder, E.7    Wigal, S.8
  • 35
    • 33646096456 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
    • 10.1016/j.biopsych.2005.09.011, 16373066
    • Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 59:829-835. 10.1016/j.biopsych.2005.09.011, 16373066.
    • (2006) Biol Psychiatry , vol.59 , pp. 829-835
    • Biederman, J.1    Mick, E.2    Surman, C.3    Doyle, R.4    Hammerness, P.5    Harpold, T.6    Dunkel, S.7    Dougherty, M.8    Aleardi, M.9    Spencer, T.10
  • 36
    • 34249791788 scopus 로고    scopus 로고
    • Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder
    • 10.1016/j.biopsych.2006.07.032, 17137560, Adult ADHD Research Group
    • Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L, . Adult ADHD Research Group Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007, 61:1380-1387. 10.1016/j.biopsych.2006.07.032, 17137560, Adult ADHD Research Group.
    • (2007) Biol Psychiatry , vol.61 , pp. 1380-1387
    • Spencer, T.J.1    Adler, L.A.2    McGough, J.J.3    Muniz, R.4    Jiang, H.5    Pestreich, L.6
  • 37
    • 52649137099 scopus 로고    scopus 로고
    • Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study
    • 10.4088/JCP.v69n0911, 19012813
    • Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry 2008, 69:1437-1448. 10.4088/JCP.v69n0911, 19012813.
    • (2008) J Clin Psychiatry , vol.69 , pp. 1437-1448
    • Spencer, T.J.1    Adler, L.A.2    Weisler, R.H.3    Youcha, S.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.